Abstract
Enterprise risk management practices are key instrument for enhancing the business performance metrics of any business entity, especially pharmaceutical firms. This study examined the nexus between enterprise risk management techniques and business performance metrics (financial perspectives, customers’ perspectives, internal business process, and learning and growth perspectives) among selected pharmaceutical companies in Lagos State. The study adopted a cross-sectional survey design cum double sampling techniques comprising purposive and convenience. The study further employed a structured questionnaire to gather data from a sample size of one hundred and sixty-four (164) participants. For descriptive statistic, simple regression technique was adopted in the data analysis. The study revealed the positively low relationship between enterprise risk management practices and business performance metrics of selected pharmaceutical companies in Lagos State, Nigeria. The study recommended that pharmaceutical companies should develop ERM framework that would provide a systematic method for detecting, evaluating, controlling, and overseeing risks. Furthermore, it is crucial to foster a culture of risk consciousness inside these organisations, wherein senior executives exhibit their dedication to risk management as an integral aspect of the business ethos. These officials should promote cooperation and transparent communication with different departments and external stakeholders, such as regulators, customers, and suppliers, to aggressively tackle risks.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call